155 related articles for article (PubMed ID: 37387737)
1. Retracted: Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9813418. PubMed ID: 37387737
[TBL] [Abstract][Full Text] [Related]
2. Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
Xiong Y; Chen T; Yu J; Zhou H; Lu B; Chen L; Sun L; Wang C; Li S; Wu B
Dis Markers; 2022; 2022():7840710. PubMed ID: 35592705
[TBL] [Abstract][Full Text] [Related]
3. Analysis of two candidate genes for Basan syndrome.
Marks KC; Banks WR; Cunningham D; Witman PM; Herman GE
Am J Med Genet A; 2014 May; 164A(5):1188-91. PubMed ID: 24664640
[TBL] [Abstract][Full Text] [Related]
4. Two
Elhaji Y; van Henten TMA; Ruivenkamp CAL; Nightingale M; Santen GW; Vos LE; Hull PR
JID Innov; 2021 Sep; 1(3):100022. PubMed ID: 34909722
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide linkage analysis and whole-genome sequencing identify a recurrent SMARCAD1 variant in a unique Chinese family with Basan syndrome.
Li M; Wang J; Li Z; Zhang J; Ni C; Cheng R; Yao Z
Eur J Hum Genet; 2016 Aug; 24(9):1367-70. PubMed ID: 26932190
[TBL] [Abstract][Full Text] [Related]
6. Huriez syndrome: Additional pathogenic variants supporting allelism to SMARCAD syndrome.
Loh AYT; Špoljar S; Neo GYW; Escande-Beillard N; Leushacke M; Luijten MNH; Venkatesh B; Bonnard C; van Steensel MAM; Hamm H; Carmichael A; Rajan N; Carney TJ; Reversade B
Am J Med Genet A; 2022 Jun; 188(6):1752-1760. PubMed ID: 35212137
[TBL] [Abstract][Full Text] [Related]
7. Ectodermal dysplasia with congenital adermatoglyphia (Basan syndrome): Report of two cases presenting with extensive congenital milia.
Nieto-Benito LM; Molina-López I; Feito-Rodríguez M; Martínez-González V; Suárez-Fernández R; Campos-Dominguez M
Pediatr Dermatol; 2021 Mar; 38(2):530-532. PubMed ID: 33486784
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
Markers D
Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Fibroblast Growth Factor 3 Is Associated with Tongue Squamous Cell Carcinoma: A Controlled Study.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9784949. PubMed ID: 37503431
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
International BR
Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9817429. PubMed ID: 37621628
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
[TBL] [Abstract][Full Text] [Related]
16. Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
International BR
Biomed Res Int; 2024; 2024():9796319. PubMed ID: 38229987
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
Markers D
Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
